3 Results for "

JAK2 activator 1

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "JAK2 activator 1" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-189252
Target:  

JAK STAT

Research Areas:  

Cancer

JAK2 activator 1 is an orally active and selective JAK2 activator derived from Proanthocyanidin A1 (HY-N2344) (EC50 = 64 nM). JAK2 activator 1 directly binds to JAK2, triggers conformational changes, and achieves allosteric activation of the JAK2/STAT3 signaling pathway. JAK2 activator 1 promotes hematopoietic recovery in chemotherapy-induced myelosuppression by protecting hematopoietic stem cells from Carboplatin (HY-17393)-induced damage. JAK2 activator 1 does not promote the proliferation of A549, HepG2, or CaCo2 tumor cells, nor does it attenuate the antitumor effect of Carboplatin. JAK2 activator 1 can be used in research related to cancer chemotherapy-induced myelosuppression .
loading...
    loading...
Cat. No.: HY-175983
CAS No.: 3026367-07-4
Target:  

JAK

Research Areas:  

Cancer

JAK1/TYK2-IN-5 (compound A1) is a JAK1/TYK2 inhibitor with Ki values of 0.0044 nM, 0.02 nM, 6.9 μM, 0.79 μM, 0.21 μM and 0.55 μM for TYK2 JH2, JAK1 JH2, JAK1 JH1, JAK2 JH1, JAK3 JH1 and TYK2 JH1, respectiverly. JAK1/TYK2-IN-5 inhibts IFNα induced TYK2/JAK1-mediated STAT activation .
loading...
    loading...
Cat. No.: HY-172596
CAS No.: 3087219-47-1
Target:  

JAK

Research Areas:  

Inflammation/Immunology

TYK2 activator-1 (16b) is a TYK2 activator with anEC50 of 1.78 μM. TYK2 activator-1 inhibits JAK2 and JAK3 with the IC50 values of 6.8 and 6.3 μM, respectively .
loading...
    loading...